Executive Summary ....5
China Pharmaceuticals And Healthcare Industry SWOT ...... 6
China Political SWOT .... 7
China Economic SWOT .. 7
China Business Environment SWOT................ 8
Pharmaceutical Business Environment Ratings ........9
Table: Pharmaceutical Business Environment Rankings For Q308 ........ 9
Limits Of Potential Returns........ 9
Risks To Realisation Of Returns ... 10
China: Market Summary .11
Regulatory Regime .12
Intellectual Property Issues ..... 13
Counterfeit Activities .... 14
Pricing And Reimbursement .... 15
Table: Five-Step Procedure For Drug Pricing In China ..... 15
Advertising Sector ......... 18
SFDA Scandal ............... 19
Other Regulatory Developments ... 20
Industry Trends And Developments ........23
Healthcare Sector ......... 23
Hospital Sector ............. 24
Epidemiology ................ 25
Overseas Activity .......... 27
Domestic Pharmaceutical Sector .. 28
Recent Developments In The Local Pharmaceutical Sector. 30
Distribution Sector ........ 30
Foreign Company Activity ....... 32
Acquisitions . 33
Traditional Chinese Medicines 33
Table: Traditional Chinese Medicine In China ... 34
R&D Activity 35
Table: Major Multinationals With R&D Facilities In China 36
Vaccine Sector .............. 37
Clinical Trials Activity .. 39
Biotechnology Sector .... 40
Active Pharmaceutical Ingredients (APIs)..... 41
Industry Forecast Scenario .43
Overall Market Forecast.......... 43
Table: China – Drug Market Data And Forecasts............... 44
Key Growth Factors – Industry 45
Table: China – Health Expenditure Data And Forecasts..... 46
Key Growth Factors – Macroeconomic ......... 47
Table: China - Economic Activity . 49
Prescription Market Forecast.. 50
Table: China – Prescription Drug Market Data And Forecasts (CNYmn unless otherwise stated) .............. 51
OTC Market Forecast ... 52
Table: China – OTC Market Data And Forecasts (US$mn unless otherwise stated) .............. 53
Generics And Patented Market Forecasts...... 54
Table: China – Generics And Patented Market Forecasts ... 55
Export/Import Forecasts .......... 56
Table: China – Pharmaceutical Trade Data And Forecasts (US$mn .... 57
Medical Device Market Forecast .. 58
China: Medical Device Market Data And Forecasts (US$bn unless otherwise stated) ........... 60
Other Healthcare Data Forecasts . 61
Table: China – Hospital Data Forecasts ....... 61
Key Risks To BMI’s Forecast Scenario.......... 62
Competitive Landscape ..63
Top Ten Chinese Pharmaceutical Companies In 2007 ........ 64
Table: Top 10 OTC Companies In China By 2006 Sales ..... 64
Top Ten Chinese Retail Pharmacy Chains In 2007.............. 65
Company Profiles ...66
Leading Multinational Companies 66
GlaxoSmithKline ........... 66
Pfizer ...... 68
AstraZeneca . 70
Merck KGaA 74
Sanofi-Aventis ............... 76
Novartis .. 78
Roche ...... 81
Merck & Co . 83
Bayer Schering Pharma 85
Indigenous Manufacturers . 87
North China Pharmaceutical Group Corporation (NCPC) . 87
China Biopharmaceuticals Holdings (CBH).. 89
Hubei Biocause Heilen Pharmaceuticalo ...... 91
Aida Pharmaceutical Holdings 93
Shijiazhuang Pharmaceutical (CSPC) ........... 95
BMI Forecast Modelling ..97
How We Generate Our Pharmaceutical Industry Forecasts ..... 97
Pharmaceutical Industry.......... 98
Pharmaceutical Business Environment Ratings Methodology .. 98
Ratings Overview .......... 98
Table: Pharmaceutical Business Environment Indicators ... 99
Weighting ... 100
Table: Weighting Of Components ................ 100
Sources ...... 100